Additional benefits of type 2 diabetes treatment found for non-alcoholic fatty liver disease patients

A type 2 diabetes treatment has been found to also have 'off-label' benefits for glucose control in the liver and in fatty cells known as adipose. The study shows that exenatide, a treatment that targets the pancreas to improve glucose absorption, enhances glucose uptake and reduces insulin resistance in the liver and in adipose tissue.

Read the whole article on Science Daily

More from Science Daily